Annals of the Rheumatic Diseases, ‎0003-4967

Journal

Publications

  1. 2009
  2. Published
  3. Published
  4. Published
  5. Published

    Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis

    Karim Raza, , Christopher Buckley, Andrew Filer & , 20 Oct 2009, In: Annals of the Rheumatic Diseases. 69, 3, p. 627-628 2 p.

    Research output: Contribution to journalArticlepeer-review

  6. 2010
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. Published

    Profound invariant natural killer T-cell deficiency in inflammatory arthritis.

    Jane Falconer, , , , & , Oct 2010, In: Annals of the Rheumatic Diseases. 69, 10, p. 1873-9

    Research output: Contribution to journalArticlepeer-review

  13. Published
  14. Published
  15. Published
  16. 2011
  17. Published

    Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

    Benjamin Fisher, , , , , , , & , 2011, In: Annals of the Rheumatic Diseases. 70, 6, p. 1095-8 4 p.

    Research output: Contribution to journalArticlepeer-review

  18. Published
  19. Published
  20. Published

    Long-term patient survival in ANCA-associated vasculitis

    Lorraine Harper, , , , , , , , , , & , 1 Mar 2011, In: Annals of the Rheumatic Diseases. 70, 3, p. 488-494 7 p.

    Research output: Contribution to journalArticle

  21. Published

    Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?

    Lorraine Harper, , , & , 1 Apr 2011, In: Annals of the Rheumatic Diseases. 70, 4, p. 707-U197

    Research output: Contribution to journalArticle

  22. Published
  23. Published